Chemistry:Geldanamycin

From HandWiki
Geldanamycin
Geldanamycin.svg
Names
IUPAC name
(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
DrugBank
UNII
Properties
C29H40N2O9
Molar mass 560.64 g/mol
Appearance Gold-yellow fine crystalline powder
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☑Y verify (what is ☑Y☒N ?)
Infobox references

Geldanamycin is a 1,4-benzoquinone ansamycin antitumor antibiotic that inhibits the function of Hsp90 (Heat Shock Protein 90) by binding to the unusual ADP/ATP-binding pocket of the protein.[1] HSP90 client proteins play important roles in the regulation of the cell cycle, cell growth, cell survival, apoptosis, angiogenesis and oncogenesis.[2]

Hsp90-geldanamycin complex. PDB 1yet[3]

Geldanamycin induces the degradation of proteins that are mutated or overexpressed in tumor cells such as v-Src, Bcr-Abl, p53, and ERBB2. This effect is mediated via HSP90. Despite its potent antitumor potential, geldanamycin presents several major drawbacks as a drug candidate such as hepatotoxicity, further, Jilani et al.. reported that geldanamycin induces the apoptosis of erythrocytes under physiological concentrations.[4] These side effects have led to the development of geldanamycin analogues, in particular analogues containing a derivatisation at the 17 position:

  • 17-AAG
  • 17-DMAG

Biosynthesis

Geldanamycin was originally discovered in the organism Streptomyces hygroscopicus.[5] It is a macrocyclic polyketide that is synthesized by a Type I polyketide synthase. The genes gelA, gelB, and gelC encode for the polyketide synthase. The PKS is first loaded with 3-amino-5-hydroxybenzoic acid (AHBA). It then utilizes malonyl-CoA, methylmalonyl-CoA, and methoxymalonyl-CoA to synthesize the precursor molecule Progeldanamycin.[6] This precursor is subjected to several enzymatic and non-enzymatic tailoring steps to produce the active molecule Geldanamycin, which include hydroxylation, o-methylation, carbamoylation, and oxidation.[7]

Notes

  1. ↑ Schulte, T. W.; Akinaga, S.; Soga, S.; Sullivan, W.; Stensgard, B.; Toft, D.; Neckers, L. M. (1998). "Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin". Cell Stress & Chaperones 3 (2): 100–108. doi:10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2. PMID 9672245. 
  2. ↑ Wayne, N.; Mishra, P.; Bolon, D.N. (2011). "Hsp90 and Client Protein Maturation". Molecular Chaperones. Methods Mol Biol.. 787. pp. 33–44. doi:10.1007/978-1-61779-295-3_3. ISBN 978-1-61779-294-6. 
  3. ↑ Stebbins, C. E.; Russo, A. A.; Schneider, C.; Rosen, N.; Hartl, F. U.; Pavletich, N. P. (1997). "Crystal structure of an Hsp90-geldanamycin complex: Targeting of a protein chaperone by an antitumor agent". Cell 89 (2): 239–250. doi:10.1016/S0092-8674(00)80203-2. PMID 9108479. 
  4. ↑ Jilani, Kashif; Qadri, Syed M.; Lang, Florian (2013). "Geldanamycin-Induced Phosphatidylserine Translocation in the Erythrocyte Membrane". Cell Physiol Biochem 32 (6): 1600–1609. doi:10.1159/000356596. PMID 24335345. 
  5. ↑ He, W.; Wu, L.; Gao, Q.; Du, Y.; Wang, Y. (2006). "Identification of AHBA Biosynthetic Genes Related to Geldanamycin Biosynthesis in Streptomyces hygroscopicus 17997". Current Microbiology 52 (3): 197–203. doi:10.1007/s00284-005-0203-y. PMID 16502293. 
  6. ↑ Kim, W.; Lee, D.; Hong, S. S.; Na, Z.; Shin, J. C.; Roh, S. H.; Wu, C. Z.; Choi, O. et al. (2009). "Rational Biosynthetic Engineering for Optimization of Geldanamycin Analogues". ChemBioChem 10 (7): 1243–1251. doi:10.1002/cbic.200800763. PMID 19308924. 
  7. ↑ Lee, D.; Lee, K.; Cai, X. F.; Dat, N. T.; Boovanahalli, S. K.; Lee, M.; Shin, J. C.; Kim, W. et al. (2006). "Biosynthesis of the Heat-Shock Protein 90 Inhibitor Geldanamycin: New Insight into the Formation of the Benzoquinone Moiety". ChemBioChem 7 (2): 246–248. doi:10.1002/cbic.200500441. PMID 16381049. 

References

  • Bedin, M.; Gaben, A. M.; Saucier, C. C.; Mester, J. (2004). "Geldanamycin, an inhibitor of the chaperone activity of HSP90, induces MAPK-independent cell cycle arrest". International Journal of Cancer 109 (5): 643–652. doi:10.1002/ijc.20010. PMID 14999769. 

External links



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Geldanamycin&oldid=206280"